CEL-SCI Corporation (CVM) Financials

CVM Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2023 28.7 million 16.1 million
Sept. 30, 2023 30.5 million 17.3 million
June 30, 2023 32.3 million 17.5 million
March 31, 2023 38.2 million 18.0 million

CVM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 -5.0 million 1.7 million
Sept. 30, 2023 -5.1 million 1.5 million
June 30, 2023 -5.9 million 1.8 million
March 31, 2023 -7.6 million 2.1 million

CVM Net Income

No data available :(

CVM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 3.2 million - 13.1 million
Sept. 30, 2023 4.1 million - 13.6 million
June 30, 2023 5.1 million 10.4 million 14.0 million
March 31, 2023 10.0 million 10.9 million 14.5 million

CVM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2023 48.5 million
Sept. 30, 2023 44.5 million
June 30, 2023 44.3 million
March 31, 2023 43.6 million

CVM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 64861 4.4 million 2.1 million -
Sept. 30, 2023 10370 5.3 million 2.2 million -
June 30, 2023 196860 5.7 million 2.5 million -
March 31, 2023 111452 6.1 million 2.1 million -

CVM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 - 1.0 million
Sept. 30, 2023 - 998653
June 30, 2023 - 988942
March 31, 2023 - 989906

CVM

Price: $1.48

52 week price:
0.89
13.48

Earnings Per Share: -3.70 USD

P/E Ratio: -1.01

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 38000

Market Capitalization: 10.2 million

Links: